Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
Dow
McKinsey
Express Scripts

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 9,931,400

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,931,400
Title:Method of combination therapy for prevention or treatment of c-Met or angiogenesis factor induced diseases
Abstract: Provided is a method of combination therapy for prevention or treatment of c-Met-induced or angiogenesis factor-induced diseases including co-administering an angiogenesis inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof to a patient.
Inventor(s): Jeong; Yun Ju (Anyang-si, KR), Kim; Kyung Ah (Seongnam-si, KR), Song; Yun Jeong (Seongnam-si, KR), Lee; Ji Min (Seoul, KR), Lee; Hyo Seon (Hwaseong-si, KR), Choi; Jae Hyun (Seongnam-si, KR), Lee; Saet Byoul (Seoul, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR)
Application Number:14/025,403
Patent Claims:see list of patent claims

Details for Patent 9,931,400

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR) 2032-09-12 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR) 2032-09-12 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
Baxter
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.